← Leaderboards
Hiroaki Mitsuya
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingHiv-1CellsVariantResistanceInfectionViralDesignPharmaceutical PreparationsStructureInhibitor/AntagonistBaseAntiviral AgentsPeptide HydrolasesDrug ResistanceProtease InhibitorActive SitesVirusAmino AcidsIn VitroComplexAcquired Immunodeficiency SyndromeReverse Transcriptase InhibitorsAntiretroviral Therapy
Grant awards (60)
Development of therapeutics for SARS-CoV-2 infection$544,510
ZIA · FY2025 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$326,707
ZIA · FY2025 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$217,804
ZIA · FY2025 · CA · contact PI
Development of therapeutics for SARS-CoV-2 infection$544,042
ZIA · FY2024 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$326,425
ZIA · FY2024 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$217,617
ZIA · FY2024 · CA · contact PI
Development of therapeutics for SARS-CoV-2 infection$508,232
ZIA · FY2023 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$304,939
ZIA · FY2023 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$203,293
ZIA · FY2023 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$778,317
ZIA · FY2022 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$259,439
ZIA · FY2022 · CA · contact PI
Development of therapeutics for SARS-CoV-2 infection$259,439
ZIA · FY2022 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$921,678
ZIA · FY2021 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$307,226
ZIA · FY2021 · CA · contact PI
Development of therapeutics for SARS-CoV-2 infection$307,226
ZIA · FY2021 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$757,665
ZIA · FY2020 · CA · contact PI
Development of therapeutics for SARS-CoV-2 infection$482,150
ZIA · FY2020 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$137,757
ZIA · FY2020 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$750,185
ZIA · FY2019 · CA · contact PI
Structural Analysis of Antiviral Activity of Novel Agents against HIV$250,062
ZIA · FY2019 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$162,539
ZIA · FY2019 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$87,522
ZIA · FY2019 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$688,944
ZIA · FY2018 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$401,884
ZIA · FY2018 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$57,411
ZIA · FY2018 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$712,356
ZIA · FY2017 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$237,452
ZIA · FY2017 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$178,089
ZIA · FY2017 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$59,363
ZIA · FY2017 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$573,550
ZIA · FY2016 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$318,638
ZIA · FY2016 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$254,910
ZIA · FY2016 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$127,455
ZIA · FY2016 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$511,192
ZIA · FY2015 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$283,995
ZIA · FY2015 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$227,196
ZIA · FY2015 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$113,598
ZIA · FY2015 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$455,222
ZIA · FY2014 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$284,513
ZIA · FY2014 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$284,513
ZIA · FY2014 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$113,805
ZIA · FY2014 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$543,985
ZIA · FY2013 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$197,812
ZIA · FY2013 · CA · contact PI
Development of Novel Agents Active against Hepatitis B Virus$148,360
ZIA · FY2013 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$98,907
ZIA · FY2013 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$755,877
ZIA · FY2012 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$215,965
ZIA · FY2012 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$107,982
ZIA · FY2012 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$694,235
ZIA · FY2011 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$198,353
ZIA · FY2011 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$99,176
ZIA · FY2011 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$392,552
ZIA · FY2010 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$392,552
ZIA · FY2010 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$196,276
ZIA · FY2010 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$462,529
ZIA · FY2009 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$462,529
ZIA · FY2009 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$231,265
ZIA · FY2009 · CA · contact PI
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors$407,970
Z01 · FY2008 · CA · contact PI
Development of Antiviral Therapy of HIV-1 Infection$305,977
Z01 · FY2008 · CA · contact PI
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors$305,977
Z01 · FY2008 · CA · contact PI